
Phase 2 clinical stroke trial on track for completion
An advanced clinical trial assessing the safety of the neuroprotective drug ARG-007 in patients who have experienced acute ischemic stroke...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Read the Perron Institute’s media statements here. See some of the Perron Institute’s media coverage here. Watch our videos on the Perron Institute YouTube channel.

An advanced clinical trial assessing the safety of the neuroprotective drug ARG-007 in patients who have experienced acute ischemic stroke...

Creativity in science was the focus of a recent exhibition showcasing artworks by first-year students studying neuroscience at The University...

Innovative medical research in stroke and dementia will be outlined at a community event presented by Western Australia’s Perron Institute...

Diagnosis of a life-limiting illness challenges the world of a patient, and spiritual resources are required to cope with the...

For the first time, researchers have published perceptions and attitudes of Western Australian young adults on the potential integration of...

A project led by Western Australian researchers has received funding to investigate whether immature white blood cells contribute to multiple...

Tourette syndrome, a neurological disorder affecting up to one per cent of the population, is characterised by sudden unwanted and...

Investing in bereavement care as a public health priority is advocated in a paper published in prestigious journal The Lancet...

Innovative research to improve outcomes for people with spinal cord injuries is among projects which attracted funding under the National...

Perron Institute was a proud sponsor of the 2024 Palliative Care Summit organised by Palliative Care WA and held in...

The Perron Institute has acknowledged with great admiration and pride the recognition received by two of its most prominent leaders...

Results of a recently published Western Australian preclinical study could help clinicians make better informed decisions on the use of...
Stay up to date with our latest news and announcements.